Trials / Completed
CompletedNCT03544684
Fasted Exercise in People With Type 1 Diabetes
Fasted High-Intensity Interval and Moderate-Intensity Continuous Exercise Are Not Associated With A Detrimental 24-Hour Blood Glucose Profile
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 14 (actual)
- Sponsor
- Liverpool John Moores University · Academic / Other
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
This study aims to compare the effect of a bout of high-intensity interval training (HIT) with a bout of moderate-intensity continuous training (MICT) on glucose concentrations over the subsequent 24h period.
Detailed description
This study aims to compare the effect of a bout of high-intensity interval training (HIT) with a bout of moderate-intensity continuous training (MICT) on glucose concentrations over the subsequent 24h period. Fourteen people with type 1 diabetes (duration of type 1 diabetes 8.2±1.4 years), all on basal-bolus regimen, completed a randomised, counterbalanced, crossover study. Continuous glucose monitoring was used to assess glycaemic control following a single bout of HIT (6 x 1min intervals) and 30 mins of moderate-intensity continuous training (MICT) on separate days, compared to a non-exercise control day (CON). Exercise was undertaken following an overnight fast with omission of short-acting insulin. Capillary blood glucose samples were recorded pre and post-exercise to assess the acute changes in glycaemia during HIT and MICT.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Effects of the type of exercise on blood glucose concentrations | glucose concentrations were assessed over the 24 hour periods following no exercise, a single bout of high intensity interval training and a single bout of moderate intensity continuous training |
Timeline
- Start date
- 2015-03-09
- Primary completion
- 2017-10-10
- Completion
- 2017-10-10
- First posted
- 2018-06-04
- Last updated
- 2018-06-11
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT03544684. Inclusion in this directory is not an endorsement.